Several key animal and laboratory studies showing that EMF exposure can disrupt the blood-brain barrier (BBB)—potentially enabling harmful substances like beta-amyloid to enter the brain.

Salford et al. and Follow-up (1994, 2008)

Study: Rats exposed to 915 MHz microwaves (continuous and pulsed) for 2 hours.

Finding: Leakage of albumin into brain tissue—a clear sign of BBB disruption

Result: 56 of 184 exposed rats showed albumin leakage versus 5 of 62 controls

Rahman et al. (2008)

Study: Male and female Wistar rats exposed to 0.9 and 1.8 GHz RF (20 minutes, under anesthesia).

Finding: Only male rats showed significant albumin (BBB) leakage—no effect in females.

Eberhardt et al. (2007)

Study: GSM-900 (mobile phone) radiation exposure.

Finding: Persistent albumin extravasation—both immediately and 7 days after a 2-hour exposure. Effects seen even at low power (0.12 mW/kg).

Electromagnetic Pulse (EMP) Study

Study: Sprague–Dawley rats exposed to 100–10,000 pulses of EMP (50 kV/m, 100 Hz).

Finding: Led to cognitive impairment, oxidative stress, and increased beta-amyloid formation.

Ultra-Wide-Band Pulses (2020)

Study: Rats exposed to broad-spectrum EM pulses.

Finding: Increased BBB permeability noted—tight-junction protein expression and other markers were altered.

Review of RF EMF Effects on BBB (2010)

Finding: BBB permeability increases only when tissue heating >1 °C; evidence for non-thermal RF effects remains inconclusive or mixed.

Connection to Beta-Amyloid & Alzheimer's

EMP exposure not only disrupts the BBB but also elevates amyloid‑β precursor and oligomer proteins.

Once BBB integrity is compromised, beta‑amyloid—central to Alzheimer's pathology—may more easily accumulate in brain tissue.

Study Exposure Effect on BBB Amyloid/Biomarkers Salford et al. 915 MHz, 2h Albumin leakage N/A Rahman et al. 0.9/1.8 GHz, 20min Male rats only albumin N/A Eberhardt et al. GSM-900, 2h Albumin leakage up to 7 days N/A EMP pulses 50 kV/m pulses Cognitive decline, oxidative stress ↑ Aβ protein UWB pulses Ultra-wide EM pulses Increased permeability, protein changes N/A 2010 review RF field overview Thermal BBB breakage possible; non-thermal is unclear

Animal models strongly suggest BBB disruption occurs with certain EMF exposures, particularly at cellular phone frequencies and electromagnetic pulses.

This disruption may enable beta-amyloid infiltration and accumulation, a known factor in Alzheimer’s disease pathology.

However, BBB effects from low-intensity or daily-life EMFs (non-thermal) remain less certain and disputed.

Does Dirty Electricity Contribute to Alzheimer’s?

Possible Biological Mechanisms (Proposed in Studies):

BBB Disrupted Repeated EMF exposure—especially in higher or pulsed frequencies—has been shown in animal studies to compromise the blood-brain barrier (BBB).
This could allow beta-amyloid, toxins, and inflammatory agents to enter the brain.
Oxidative Stress & Neuroinflammation:
Studies on both EMFs and dirty electricity suggest they can generate reactive oxygen species (ROS) in brain tissue, contributing to neurodegeneration.
Circadian Disruption & Melatonin Suppression:
EMFs, including those from smart meters, may interfere with melatonin—an important antioxidant that protects neurons and regulates sleep.
Electrohypersensitivity (EHS)
Though controversial, some individuals report memory loss, confusion, and brain fog in proximity to smart meters or high-DE environments. These symptoms are consistent with cognitive decline markers.

Do Countries with Smart Meters Show More Dementia?

Not Conclusively Proven, but correlations are being observed:

High smart meter and Wi-Fi saturation countries (USA, UK, parts of Europe, Australia) also report rising early-onset dementia.
But these same countries also have:
Older populations
More screening
Better reporting systems

So while correlation exists, causation hasn't been proven.

Example Comparison (Approximate):

Country Smart Meter Rollout Dirty Electricity Concerns Alzheimer’s Prevalence (65+) USA ~80% of homes High; solar, Wi-Fi, smart tech ~11% (CDC, 2023) UK >50% rollout Similar issues ~7.1% (Alzheimer’s Society) Japan Extensive rollout High population density EMF ~7.3% India Low rollout Lower DE, but more pollution ~1.5–2% (underreported) Rural Africa Minimal tech Low EMF 6 months) Still under study, especially for IV use PTSD/Suicide outcomes Emerging evidence in both civilian and veteran studies VA research Expanding quickly, supported by Diffusion of Excellence programs How does ketamine affect perception?

Dissociation: The Core Effect

Ketamine is classified as a dissociative anesthetic. It creates a sense of detachment from the body, mind, and environment. People may feel like they are observing themselves from outside their body, an “out-of-body experience” or that time and space are distorted.

Emotional and Cognitive Disconnection

Ketamine can numb emotional responses and temporarily blunt feelings of anxiety or depression. Some users experience a sense of being cut off from their thoughts or surroundings. This effect is one reason ketamine is being explored as a treatment for depression, as it can interrupt rigid, negative thought patterns.

The “K-hole” Experience

At high doses, ketamine can induce a very deep dissociative state often referred to as a “K-hole.” This state involves near-total disconnection from sensory input, personal identity, and, in some cases, reality itself. The experience can feel profound, terrifying, or euphoric, depending on the setting, dosage, and the individual's mental state.

Medical Use

In controlled medical environments, small doses of ketamine are used for a variety of purposes. These include anesthesia, pain relief, and, more recently, the rapid alleviation of symptoms in individuals with treatment-resistant depression.

Risks of Disconnection

While the disconnection effects of ketamine can be therapeutic in a medical context, recreational or unsupervised use carries risks. These include confusion, panic attacks or “bad trips,” memory problems, and an increased likelihood of accidents or injury due to impaired coordination and awareness.

Public Figures and Ketamine Use

Elon Musk has publicly acknowledged using ketamine, stating that it helps with his depression and enhances his productivity. He discussed this on X (formerly Twitter), and it was later confirmed in reports by media outlets including The Wall Street Journal and The New York Times.

What about Peter Thiel?

There is no confirmed public admission or verified report that Peter Thiel takes ketamine.

However, Peter Thiel has a long-standing interest in life extension, transhumanism, and experimental medicine, including:

Funding anti-aging research

Supporting companies involved in cryonics, parabiosis (young blood plasma infusions), and nootropics

Associating with controversial longevity and biohacking ventures

Because of this, some speculate that Thiel might be open to substances like ketamine as part of cutting-edge therapies, but:

There is no credible source confirming that Peter Thiel uses ketamine.

Public Figures Linked to Ketamine Use or Advocacy

Elon Musk

Status: Confirmed userElon Musk has openly discussed his use of ketamine to treat depression. He has emphasized its positive effects on both mood and productivity.Musk has suggested that while some people benefit from SSRIs, for him, “ketamine works better.”

Kristen Bell

Status: Supporter of psychedelic-assisted therapyWhile Kristen Bell has not publicly endorsed ketamine specifically, she has been open about her mental health struggles and has voiced support for psychedelic research in general. She is associated with broader advocacy efforts surrounding psychedelic-assisted mental health treatment.

Aaron Rodgers

Status: Psychedelic user (not ketamine)NFL quarterback Aaron Rodgers has spoken about his use of ayahuasca, a DMT-based psychedelic. He describes his experiences as spiritually transformative and healing, advocating for the destigmatization of altered states in personal and emotional growth.

Gwyneth Paltrow

Status: Supporter of psychedelic therapyThrough her lifestyle brand Goop, Gwyneth Paltrow has explored and featured content on ketamine-assisted therapy and broader psychedelic wellness practices. Her involvement has helped bring attention to these topics in mainstream wellness discussions.

Dr. John Krystal

Status: Leading medical expertContext: A psychiatrist at Yale University, Dr. John Krystal is one of the earliest researchers to explore ketamine’s use as a treatment for depression. His clinical work has been instrumental in legitimizing ketamine as a fast-acting antidepressant within the medical community.

Dr. Carl Hart

Status: Public advocate for rational drug policyContext: As a neuropsychopharmacologist at Columbia University, Dr. Carl Hart advocates for science-based, responsible discussion and policy regarding psychoactive substances. He supports research and adult use of ketamine in appropriate contexts, emphasizing informed, rational approaches to drug use.

Tech & Venture Capital Circles

While not all have admitted ketamine use, many in Silicon Valley are deeply involved in psychedelic research and funding, such as:

Peter Thiel

Peter Thiel, co-founder of Palantir and an early investor in Facebook, has become a significant figure in the emerging field of psychedelic medicine. He has invested in startups like ATAI Life Sciences, a company that researches treatments using substances such as psilocybin, ketamine, and MDMA.

Thiel is also a vocal proponent of radical medical innovation, life extension, and anti-aging science. While there is no confirmed evidence that he personally uses ketamine, his role as a financial backer makes him a key player in the industry's development and legitimization.

White House Drug Testing Policy: History and Changes When Did Drug Testing in the White House Begin?

Drug testing in the White House began in the 1980s during President Ronald Reagan’s administration, coinciding with the broader “War on Drugs.” This initiative aimed to ensure federal employees, particularly those in national security or sensitive roles, were held to strict drug-free standards.

The policy was formalized with Executive Order 12564, signed in 1986, which declared that the Federal Government is a drug-free workplace. Under this order, White House staffers, especially those with security clearances, could be subject to:

Random drug testing
Pre-employment drug screening
Drug testing following incidents or reasonable suspicion

These procedures became a standard part of maintaining trust and safety within federal operations.

Did Donald Trump Eliminate Drug Testing at the White House?

There is no official record, executive order, or documented memo indicating that the Trump administration formally ended the White House’s drug testing policy. However, multiple news reports and whistleblower claims, particularly in 2020, alleged that drug screening procedures were largely ignored or deprioritized during Trump’s time in office.

According to outlets such as Axios and Politico, White House staffers were reportedly not undergoing routine drug tests, even during the COVID-19 era when workplace policies were under heightened scrutiny. These reports raised concerns about the lax enforcement of what had previously been a strict protocol.

Was This Due to Trump’s Own Alleged Drug Use?

There is no verified evidence that Trump ended or relaxed drug testing due to his own drug use. However, rumors have circulated, particularly from former aides and critics. For example, Noel Casler, a former staffer on The Celebrity Apprentice, alleged that Trump abused Adderall. These claims remain unconfirmed and have not been supported by medical documentation. Trump himself has never publicly admitted to using Adderall, stimulants, or any illegal substances.

Public Figures and Drug or Hormone Use: A Broader Discussion

Elon Musk – Ketamine

In 2023, Elon Musk publicly acknowledged using prescribed ketamine to manage depression. He stated that the medication helps him break free from “negative mental loops.” Ketamine is not illegal when prescribed and is FDA-approved in specific formulations (such as Spravato) for treatment-resistant depression.

Despite its legality, Musk's use has sparked debate due to his role leading SpaceX, a major defense contractor. Critics have questioned whether such use should raise concerns given his security-sensitive responsibilities. Musk has defended his approach, claiming ketamine is a preferable alternative to SSRIs.

RFK Jr. – Testosterone Therapy

Robert F. Kennedy Jr. has disclosed that he has used testosterone replacement therapy. He reportedly began this regimen to restore energy levels following health complications. Testosterone therapy is legal with a prescription, though its use—particularly at high doses or for non-medical enhancement—is sometimes viewed as controversial in medical and athletic communities.

Joe Rogan – Hormones and Performance Enhancers

Joe Rogan has openly discussed his use of testosterone, human growth hormone (HGH), and peptides. He considers these substances part of his longevity and performance strategy. Although none of these substances are illegal when prescribed, Rogan’s openness contributes to a larger public debate over the normalization of such therapies, especially among men in high-profile positions in media and politics.

Summary Table

Person Admitted Substance Legal? Public Concern? Trump Rumored Adderall Not confirmed Yes – if true, raises questions about medical fitness and leadership Musk Ketamine (prescribed) Legal Yes – due to defense industry ties and executive responsibilities RFK Jr. Testosterone Legal Yes – concerns about transparency, ethics, and performance enhancement Rogan TRT, HGH, peptides Legal Yes – influential public figure shaping health and lifestyle norms

The trend among powerful men toward prescription-based enhancement — whether it’s ketamine, testosterone, or nootropics — is increasingly visible. While legal in many cases, it raises:

Ethical questions (Should leaders be transparent about their mental health treatments?)

Security concerns (What happens if a world leader is chemically altered?)

Cultural shifts (Are we normalizing “biohacking” as elite self-care?)

TIMELINE: Public Admissions or Reports of Drug Use Among Elites Year Person Substance Type Context 1976 Jimmy Carter’s son (Chip Carter) Marijuana Illegal (then) Arrested for possession while his father was campaigning. 1980s–1990s Bill Clinton Marijuana Illegal (then) Famously claimed: “I didn’t inhale.” 2006 Barack Obama (in memoir) Cocaine, marijuana Illegal Admitted past use in Dreams from My Father. 2016 Joe Rogan Testosterone, HGH Legal (prescribed) Discussed openly on podcast; used for fitness and longevity. 2019 Robert F. Kennedy Jr. Testosterone Legal (prescribed) Admitted use in interviews, citing declining health. 2021 Elon Musk Psychedelics (implied), Ketamine Legal (prescribed) Stated he uses ketamine “occasionally” for depression. 2020–2023 Donald Trump (rumors) Adderall (rumored) Unconfirmed Former staffers alleged stimulant use; no official confirmation or records. 2023 Aaron Rodgers Ayahuasca Illegal (U.S.), Legal abroad Said it helped him “transform” and improve performance. 2024 Robert F. Kennedy Jr. Testosterone Legal Confirmed again during campaign interviews. Ongoing Silicon Valley execs (e.g., Bryan Johnson, David Asprey) Nootropics, testosterone, peptides Legal Promoting “biohacking” and performance enhancement as a lifestyle.

Elite use is often done under concierge medicine or offshore protocols to bypass scrutiny.

Trends Among the Elite

In elite circles—especially within Silicon Valley—there is a growing trend of using pharmacological and technological tools to enhance performance and well-being. Microdosing psychedelics, taking modafinil, and using bio-identical hormones have become common topics in private networks and among startup founders.

Podcast culture, driven by influential voices like Joe Rogan, Robert F. Kennedy Jr., and Dr. Andrew Huberman, has further normalized the use of testosterone, nootropics, and other enhancement drugs. These substances are often adopted by high-functioning executives and political candidates to combat burnout, cognitive decline, or depression. However, they are not always disclosed publicly, raising questions of transparency and ethics.

Ethical Questions Being Raised

As elite biohacking becomes more visible, several ethical concerns are gaining prominence:

Should public figures be required to disclose their use of substances that could affect cognition or behavior?
Are these developments creating two separate health systems—one for elite enhancement and another for the general population?
What national security risks emerge if leaders use mind-altering or mood-regulating substances?
In an age of enhancement, how should we define cognitive fitness or mental competence for office?

Part 1: Popular Biohacker Stacks Among the Elite

“Stacks” refer to personalized combinations of supplements, medications, and practices aimed at improving cognitive function, mood, longevity, or physical performance. Below is a breakdown of popular biohacking stacks among tech founders, wellness influencers, and longevity enthusiasts.

Bryan Johnson’s Blueprint Stack

Bryan Johnson, the tech entrepreneur behind Braintree and Venmo, spends more than $2 million per year attempting to reverse biological aging through an intensive and data-driven health protocol. His regimen is one of the most comprehensive and publicized in the biohacking world.

The ultra-wealthy tech founder (Braintree/Venmo) who spends over $2 million/year trying to reverse aging.

Category Substances/Practices Hormonal Testosterone (microdosed), DHEA Peptides GHK-Cu, BPC-157, Thymosin Beta-4 Supplements NMN, resveratrol, vitamin D, magnesium, omega-3, glycine, creatine, pterostilbene Nootropics Nicotine gum (microdosed), caffeine (limited), L-theanine Medications Metformin (off-label for longevity), rapamycin (off-label, anti-aging) Devices Red light therapy, plasma apheresis, full-body MRI/ultrasound tracking Diet Strict calorie-controlled vegan diet with biomarker tracking Sleep Protocol Full circadian alignment routine, sleep supplements like magnesium threonate, melatonin Silicon Valley “Executive Stack” Function Substances Cognitive Boost Modafinil, Adderall (off-label), Alpha-GPC, L-tyrosine, noopept Mood/Stability Ketamine (prescribed), microdosed psilocybin, ashwagandha Longevity Metformin, NAD+ boosters (e.g., NMN, NR), resveratrol, rapamycin Fitness/Recovery Testosterone (TRT), HGH, peptides (BPC-157, TB-500), creatine Sleep/Recovery Magnesium glycinate, melatonin, glycine, apigenin (recommended by Huberman) Lifestyle Sauna, cold plunge, neurofeedback, 5-day fasting, stem cell injections (abroad)

What Disqualifies Someone from the U.S. Security Clearance?

Security clearance (Confidential, Secret, or Top Secret) is determined by the Defense Counterintelligence and Security Agency (DCSA) and guided by Adjudicative Guidelines for Determining Eligibility for Access to Classified Information.

Substances That Can Disqualify or Flag Applicants:

Substance Risk Clearance Impact Adderall (without Rx) Controlled substance misuse Likely denial Cocaine, LSD, MDMA Schedule I, past use Can disqualify or delay Ketamine (non-medical use) Schedule III Prescribed = generally OK; misuse = risky Marijuana Still federally illegal Past use may be OK (if disclosed), recent use = denial TRT/Testosterone Prescription only Legal = generally OK unless abused or undeclared Modafinil Schedule IV Legal with Rx; abuse = red flag Psychedelics Illegal federally Use = disqualifier unless distant past + disclosed Steroids (AAS) Schedule III Abuse = denial; TRT with Rx = OK Off-label drugs (e.g., Metformin for aging) Not disqualifying OK if medically supervised Nootropic compounds (Noopept, racetams) Not FDA-approved Case-by-case (imported substances = red flag) Alcohol abuse Major red flag Requires documented rehabilitation, sobriety period

Dishonesty during the application is often worse than past drug use. The government emphasizes full disclosure.

What Is Generally Acceptable?

Prescribed medications, including testosterone, ketamine (Spravato), or modafinil, are generally acceptable if taken under medical supervision, disclosed clearly, and not abused or used to avoid necessary rest or function.

Biohacking routines such as supplements, sleep trackers, red light therapy, and fasting are usually not an issue unless they are tied to risky behavior or medical fraud.

Key Takeaways

Elites are increasingly using pharmacology combined with technology for enhancement, but much of this exists in a legal gray zone. Security clearance depends not only on the substances used but also on honesty, patterns of behavior, and intent.

The government remains cautious about foreign-supplied or experimental compounds, especially if they indicate impulsivity or poor judgment.

Elite Biohacking & Longevity Clinics

Extension Health – New York City

Founded by Dr. Jonathann Kuo, Extension Health offers services including plasma exchange, peptide therapy, gene therapy, neuro resets, and comprehensive diagnostics. Membership tiers include a standard package at $10,000 per year and a “Superhuman” package at $250,000 per year, available by invitation only. Their clientele includes celebrities, tech founders, and royalty, with notable clients such as La La Anthony and Kimbal Musk.

Wild Health – Executive Concierge Program

Wild Health follows a precision medicine approach, providing personalized care plans based on individual data. Services include genomic testing, advanced biomarker analysis, and longevity protocols. The target audience is executives seeking to extend their healthspan and performance.

Sydenham Clinic – Houston, TX

Sydenham Clinic focuses on personalized health management through genetic and biomarker analysis. It offers comprehensive concierge medicine and anti-aging strategies, operating independently of insurance and pharmaceutical-driven care.

GitelCare – Miami, FL

GitelCare offers Biohacking 360 Executive Physicals, advanced lab testing, in-depth health analysis, and 24/7 concierge support. Its target audience is VIP clients seeking premium wellness services.

Elite Concierge Physicians

This practice emphasizes holistic, patient-centered care, blending virtual and home visits with personalized health plans. Their goal is to empower patients to actively manage their health and well-being.

WorldClinic

WorldClinic provides on-demand, comprehensive concierge medical services for executives and employers, offering personalized care accessible anytime and anywhere. Its target audience consists of high-net-worth individuals requiring global medical support.

Members.MD – Omaha, NE

Members.MD specializes in concierge primary care focused on personalized health management through direct physician relationships and tailored health plans. Their target audience includes health-conscious individuals seeking control over their health.

Additional Noteworthy Clinics

Longevity Medical Institute – San José del Cabo, Mexico

This 15,000 sq ft facility offers concierge medicine, biohacking, anti-aging, and personalized health programs.

MD² (MD Squared)

MD² offers innovative concierge medicine with tailored care systems, focusing on comprehensive health management for discerning clients.

Lifetime risk of dementia after age 55 is double previous estimates - White House and Illegal Drug Use by Musk and Trump. Alzheimer and Dirty Electricity. What is the connection? Tests on RATS confirm how we are getting Alzheimers, no HUMAN studies 01:25:45 Share

Psychopath In Your Life with Dianne Emerson

Shownotes Transcript

Lifetime risk of dementia after age 55 is double previous estimates - White House and Illegal Drug Use by Musk and Trump. Alzheimer and Dirty Electricity. What is the connection? Tests on RATS confirm how we are getting Alzheimers, no HUMAN studies